| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |